Grifois (GRFS) Stock: Buy, Sell, or Hold?
$8.80
-0.04 (-0.45%)
▼
5d:
+4.02%
30d:
+21.55%
90d:
+13.11%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (25%)
Quality Score
26/100
Position
EXTENDED
30-Day Fair Range
$7.40 – $8.46
Position: EXTENDED
Forward P/E & Valuation
7.1x
STRETCHED
vs 5.8x historical avg
Wall Street Target
$10.37
+17.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.05 / $8.89
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: GRFS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When GRFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.05
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$8.73
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GRFS is currently trading at $8.80, which is considered extended relative to its 30-day fair value range of $7.40 to $8.46. From a valuation perspective, the stock is trading at a premium (Forward PE: 7.1) compared to its historical average (5.8). At these levels, the market is pricing in 6.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GRFS is in a uptrend. The price is approaching resistance at $8.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GRFS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.37 (+17.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRFS is in a uptrend. The price is approaching resistance at $8.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GRFS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.37 (+17.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.40 -
$8.46
Company Quality Score
26/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
25.2%
Trading Range & Key Levels
30-Day Trading Range
$7.40 -
$8.46
Current vs Trading Range
EXTENDED
Support Level
$8.05
Resistance Level
$8.89
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($10.37)
- NEUTRAL: Trading at premium valuation - market expects 6.8% growth which is achievable
- WARNING: Composite score 26/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
7.07
Wall Street Target
$10.37
(+17.8%)
Revenue Growth (YoY)
9.4%
Earnings Growth (YoY)
32.9%
Profit Margin
6.4%
Valuation Premium vs History
+6.8% premium
PE vs Historical
7.1 vs 5.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.8%
(market-implied from PE analysis)
1-Year Target
$9.40
(+7%)
2-Year Target
$10.04
(+14%)
3-Year Target
$10.72
(+22%)
3-Yr Target (if PE normalizes)
(PE: 7→6)
PE COMPRESSION
$8.79
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 32.6%)
$57.59
(+555%)
Base:
(SPY PE: 7.1, Growth: 32.6%)
$20.51
(+133%)
Bear:
(PE: 5.8, Growth: 32.6%)
$16.82
(+91%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 10.65 | Current EPS (TTM): $0.83
Bull Case
$14.58
(+66%)
Analyst growth 49.9%, PE expands to 11.7
Base Case
$13.25
(+51%)
Market implied 49.9%, PE stable at 10.7
Bear Case
$6.01
(-32%)
Severe decline -20.0%, PE contracts to 9.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share GRFS Analysis
Share this live GRFS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GRFS)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Nov 6, 2025
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on GRFS are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$306 | 55 HOLD |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$266 | 45 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 45 HOLD |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 54 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1453 | 26 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GRFS Research Pages
